Chilean biotech Protera Biosciences is heading for the city of lights, having closed $5.5m (â4.9m) Series A financing led by Sofinnova Partners. Europe, Protera CEO Leonardo Ãlvarez tells FoodNavigator, is known for its âvast expertiseâ in producing enzymes and proteins at industrial scale.
Read more about it via https://www.foodnavigator.com/Article/2020/06/17/Protera-CEO-talks-AI-developed-proteins-closing-5m-Series-A-and-relocating-to-France?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS
No comments:
Post a Comment